288 related articles for article (PubMed ID: 24872516)
1. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
[TBL] [Abstract][Full Text] [Related]
3. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
[TBL] [Abstract][Full Text] [Related]
4. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
6. Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.
Liu X; Liu Y; Zhang Y; Chen Z; Tang Z; Xu Q; Wang Y; Zhao P; Qi Z
PLoS One; 2013; 8(3):e58810. PubMed ID: 23527030
[TBL] [Abstract][Full Text] [Related]
7. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
[TBL] [Abstract][Full Text] [Related]
8. Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine.
He XS; Sasaki S; Baer J; Khurana S; Golding H; Treanor JJ; Topham DJ; Sangster MY; Jin H; Dekker CL; Subbarao K; Greenberg HB
J Infect Dis; 2013 Jan; 207(2):288-96. PubMed ID: 23107783
[TBL] [Abstract][Full Text] [Related]
9. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.
Matsuzaki Y; Sugawara K; Nakauchi M; Takahashi Y; Onodera T; Tsunetsugu-Yokota Y; Matsumura T; Ato M; Kobayashi K; Shimotai Y; Mizuta K; Hongo S; Tashiro M; Nobusawa E
J Virol; 2014 Nov; 88(21):12364-73. PubMed ID: 25122788
[TBL] [Abstract][Full Text] [Related]
11. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
12. Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.
Valkenburg SA; Zhang Y; Chan KY; Leung K; Wu JT; Poon LL
J Infect Dis; 2016 Oct; 214(8):1159-63. PubMed ID: 27493238
[TBL] [Abstract][Full Text] [Related]
13. Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.
Daulagala P; Mann BR; Leung K; Lau EHY; Yung L; Lei R; Nizami SIN; Wu JT; Chiu SS; Daniels RS; Wu NC; Wentworth D; Peiris M; Yen HL
mBio; 2023 Jun; 14(3):e0008423. PubMed ID: 37070986
[TBL] [Abstract][Full Text] [Related]
14. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
[TBL] [Abstract][Full Text] [Related]
16. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.
Li GM; Chiu C; Wrammert J; McCausland M; Andrews SF; Zheng NY; Lee JH; Huang M; Qu X; Edupuganti S; Mulligan M; Das SR; Yewdell JW; Mehta AK; Wilson PC; Ahmed R
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9047-52. PubMed ID: 22615367
[TBL] [Abstract][Full Text] [Related]
17. Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.
Huijskens EG; Reimerink J; Mulder PG; van Beek J; Meijer A; de Bruin E; Friesema I; de Jong MD; Rimmelzwaan GF; Peeters MF; Rossen JW; Koopmans M
PLoS One; 2013; 8(1):e54890. PubMed ID: 23365683
[TBL] [Abstract][Full Text] [Related]
18. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic.
Reed C; Katz JM; Hancock K; Balish A; Fry AM;
PLoS One; 2012; 7(10):e48187. PubMed ID: 23118949
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M
J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
